National Health Investors (NHI) Earning Somewhat Positive Media Coverage, Report Shows

Media headlines about National Health Investors (NYSE:NHI) have been trending somewhat positive this week, according to Accern. Accern rates the sentiment of media coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. National Health Investors earned a news impact score of 0.19 on Accern’s scale. Accern also gave press coverage about the real estate investment trust an impact score of 46.1754639451921 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

Shares of NYSE:NHI opened at $73.87 on Wednesday. The company has a current ratio of 15.21, a quick ratio of 15.21 and a debt-to-equity ratio of 0.88. The company has a market capitalization of $3.08 billion, a PE ratio of 13.86, a PEG ratio of 3.84 and a beta of 0.46. National Health Investors has a 1 year low of $62.71 and a 1 year high of $81.60.

National Health Investors (NYSE:NHI) last issued its quarterly earnings results on Tuesday, May 8th. The real estate investment trust reported $0.92 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.34 by ($0.42). The firm had revenue of $72.75 million during the quarter, compared to analyst estimates of $72.04 million. National Health Investors had a return on equity of 11.69% and a net margin of 53.88%. The business’s revenue was up 9.6% on a year-over-year basis. During the same period in the prior year, the firm earned $1.25 earnings per share. research analysts anticipate that National Health Investors will post 5.5 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 10th. Shareholders of record on Friday, June 29th will be paid a dividend of $1.00 per share. This represents a $4.00 dividend on an annualized basis and a yield of 5.41%. The ex-dividend date is Thursday, June 28th. National Health Investors’s dividend payout ratio (DPR) is currently 75.05%.

Several analysts have commented on the company. Wells Fargo & Co set a $75.00 price objective on National Health Investors and gave the company a “market perform” rating in a report on Thursday, May 31st. They noted that the move was a valuation call. Cantor Fitzgerald reissued a “hold” rating and issued a $75.00 price objective on shares of National Health Investors in a report on Tuesday, May 8th. KeyCorp dropped their price objective on National Health Investors from $70.00 to $60.00 and set a “sell” rating on the stock in a report on Tuesday, April 17th. BMO Capital Markets set a $70.00 price objective on National Health Investors and gave the company a “hold” rating in a report on Monday, March 26th. Finally, Capital One Financial raised National Health Investors from an “equal weight” rating to an “overweight” rating in a report on Friday, May 11th. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and four have issued a buy rating to the stock. National Health Investors currently has a consensus rating of “Hold” and an average target price of $73.44.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Insider Buying and Selling by Quarter for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply